Hepatitis C virus treatment for prevention among people who inject drugs: Modeling treatment scale-up in the age of direct-acting antivirals

Substantial reductions in hepatitis C virus (HCV) prevalence among people who inject drugs (PWID) cannot be achieved by harm reduction interventions such as needle exchange and opiate substitution therapy (OST) alone. Current HCV treatment is arduous and uptake is low, but new highly effective and t...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Martin, Natasha K, Vickerman, Peter, Grebely, Jason, Hellard, Margaret, Hutchinson, Sharon J, Lima, Viviane D, Foster, Graham R, Dillon, John F, Goldberg, David J, Dore, Gregory J, Hickman, Matthew
Formato: Artigo
Lenguaje:Inglês
Publicado: Blackwell publishing Ltd 2013
Materias:
Viral Hepatitis
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3933734/
https://ncbi.nlm.nih.gov/pubmed/23553643
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/hep.26431
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares